Skip to content
10-Q

Quarterly Report

CTT PHARMACEUTICAL HOLDINGS, INC. CTTH

0001553350-15-001276

← back to feed
Filed
Nov 23, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 15, 2015 21.35M sh
Operating Cash Flow Q3 2015 · Sep 30, 2015 −$84.34K
Operating Cash Flow Q3 2015 · Sep 30, 2014 −$25.41K
Cash And Equivalents Q3 2015 · Sep 30, 2015 $32.12K
Cash And Equivalents Q3 2015 · Dec 31, 2014 $81.18K
Cash And Equivalents Q3 2015 · Sep 30, 2014 $125.32K
Stockholders Equity Q3 2015 · Sep 30, 2015 $738.08K
Stockholders Equity Q3 2015 · Dec 31, 2014 $1.49M
Stockholders Equity restated Q3 2015 · Dec 31, 2013 −$29.32K
Stockholders Equity restated Q3 2015 · Dec 31, 2012 −$20K
Total Liabilities Q3 2015 · Sep 30, 2015 $183.96K
Total Liabilities Q3 2015 · Dec 31, 2014 $169.49K
Current Assets Q3 2015 · Sep 30, 2015 $922.04K
Current Assets Q3 2015 · Dec 31, 2014 $1.05M
Total Assets Q3 2015 · Sep 30, 2015 $922.04K
Total Assets Q3 2015 · Dec 31, 2014 $1.66M
Sga Expense Q3 2015 · Sep 30, 2015 $14.93K
Sga Expense Q3 2015 · Sep 30, 2015 $54.28K
Sga Expense Q3 2015 · Sep 30, 2014 $12.95K
Sga Expense Q3 2015 · Sep 30, 2014 $13.07K
Net Income Q3 2015 · Sep 30, 2015 −$341.93K
Net Income Q3 2015 · Sep 30, 2015 −$1.04M
Net Income Q3 2015 · Dec 31, 2014 −$672.16K
Net Income Q3 2015 · Sep 30, 2014 −$43.2K
Net Income Q3 2015 · Sep 30, 2014 −$43.64K
Net Income Q3 2015 · Dec 31, 2013 −$18.91K